Walleye Capital LLC Y M Abs Therapeutics, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.83 - $5.11 $31,715 - $57,267	-11,207 Reduced 29.03%	27,393 $137,000
Q4 2022 Feb 14, 2023	SELL	$3.0 - $15.17 $1.2 Million - $6.05 Million	-398,744 Reduced 91.17%	38,600 $188,000
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $296,007 - $417,082	21,204 Added 5.1%	437,344 $6.31 Million
Q2 2022 Aug 08, 2022	BUY	$8.22 - $15.13 $3.42 Million - $6.3 Million	416,140 New	416,140 $6.3 Million
Q1 2022 May 16, 2022	SELL	$6.55 - $17.42 $112,581 - $299,414	-17,188 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$15.51 - $29.31 $266,585 - $503,780	17,188 New	17,188 $278,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.